Women informed of over-detection risk less likely to want mammography

the ONA take:

According to a new study published in the journal The Lancet, researchers have found that women who are better informed about the risk of over-detection and over-diagnosis associated with mammography screening are less likely to have a breast cancer screening.

Mammography screening can prevent deaths associated with breast cancer, but most women are unaware that the screening can lead to over-diagnosis and overtreatment.

For the study, researchers randomly assigned 879 women aged 48-50 years who were about to become candidates for mammography screening to receive decision support materials with or without over-detection information.

Results showed that compared with controls, more women provided with over-detection information had adequate knowledge about breast cancer screening and made an informed choice about whether to be screened, had less favorable attitudes towards breast cancer screening, and had fewer intentions to be screened for breast cancer. 

The findings suggest the importance of giving women clear decision support materials so that they can make more informed decisions about whether they should receive a mammography screening.

Adding carboplatin to chemotherapy is promising for triple-negative breast cancer
Women who are better informed about the risk of over-detection are less likely to have a breast cancer screening.
Women who understand the risk of over-detection and over-diagnosis associated with mammography screening have lower intentions to have a breast screening test, according to a new Lancet study.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs